The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020

This section has no associated Explanatory Memorandum

99.  For regulation 132 (omission of Part 8), substitute—U.K.

Amendment of regulation 156 (article 126a authorisations)

132.  In regulation 156—

(a)in paragraph (1)—

(i)after “126a authorisation for” insert “ sale or supply of ”;

(ii)after “medicinal product” insert “ in Northern Ireland only, ”;

(b)in paragraph (2), after “is in force” insert “ in Northern Ireland ”;

(c)in paragraph (3), after “traditional herbal registration” insert “ to be in force in Northern Ireland ”;

(d)in paragraph (4) for “the United Kingdom” substitute “ Northern Ireland ”; and

(e)in paragraph (5) for “another member State” substitute “ an EU member State ”.

Amendment of regulation 157 (requests from other member States)

132A.  In regulation 157(1)—

(a)in the heading for “other member States” substitute “ EU member States ”; and

(b)in paragraph (1)—

(i)after “where the licensing authority” insert “ , in relation to a UKMA(NI), ”; and

(ii)for “another member State” substitute “ a member State ”..

Commencement Information

I1Sch. 2 para. 99 in force at 31.12.2020 immediately before IP completion day, see reg. 1